---
figid: PMC11617596__MCO2-5-e70026-g001
figtitle: Ac4C‐related signaling pathway in cancer
organisms:
- NA
organisms_ner:
- Homo sapiens
pmcid: PMC11617596
filename: MCO2-5-e70026-g001.jpg
figlink: /pmc/articles/PMC11617596/figure/F4/
number: F4
caption: Overview of the ac4C‐related signaling pathway in cancer. In cancer cells,
  activation of the NF‐κB signaling pathway promotes NAT10 expression. Activated p65
  binds to the NAT10 promoter and regulates its expression in a transcriptional manner.
  NAT10, inhibited by Remodelin, mediates mRNA ac4C modification and promotes the
  downstream protein expression thereby activating the Wnt/β‐catenin pathway. NAT10
  boosts c‐Myc upregulation, regulates cell cycle and EMT through activation of the
  Wnt/β‐catenin pathway, ultimately promoting tumor progression. NF‐κB, nuclear factor
  kappa‐B; TCF/LEF, T‐cell factor/lymphoid enhancer‐binding factor. TLR, Toll‐like
  receptor; EMT, epithelial–mesenchymal transition
papertitle: The role and mechanism of NAT10‐mediated ac4C modification in tumor development
  and progression
reftext: Zhuoran Gu, et al. MedComm (2020). 2024 Dec;5(12).
year: '2024'
doi: 10.1002/mco2.70026
journal_title: MedComm
journal_nlm_ta: MedComm (2020)
publisher_name: Wiley
keywords: cancer | epitranscriptome | N4‐acetylation (ac4C) | N‐acetyltransferase
  10 (NAT10) | RNA modification
automl_pathway: 0.9522865
figid_alias: PMC11617596__F4
figtype: Figure
redirect_from: /figures/PMC11617596__F4
ndex: ''
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC11617596__MCO2-5-e70026-g001.html
  '@type': Dataset
  description: Overview of the ac4C‐related signaling pathway in cancer. In cancer
    cells, activation of the NF‐κB signaling pathway promotes NAT10 expression. Activated
    p65 binds to the NAT10 promoter and regulates its expression in a transcriptional
    manner. NAT10, inhibited by Remodelin, mediates mRNA ac4C modification and promotes
    the downstream protein expression thereby activating the Wnt/β‐catenin pathway.
    NAT10 boosts c‐Myc upregulation, regulates cell cycle and EMT through activation
    of the Wnt/β‐catenin pathway, ultimately promoting tumor progression. NF‐κB, nuclear
    factor kappa‐B; TCF/LEF, T‐cell factor/lymphoid enhancer‐binding factor. TLR,
    Toll‐like receptor; EMT, epithelial–mesenchymal transition
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - CD40
  - ARHGEF7
  - ASCC1
  - H3P40
  - REL
  - RELA
  - SYT1
  - GORASP1
  - WNK1
  - CRE1
  - TLR1
  - TLR2
  - TLR3
  - TLR4
  - TLR5
  - TLR6
  - TLR7
  - TLR8
  - TLR9
  - TLR10
  - WNT1
  - WNT2
  - WNT2B
  - WNT3
  - WNT3A
  - WNT4
  - WNT6
  - WNT7A
  - WNT7B
  - WNT8A
  - WNT8B
  - WNT9A
  - WNT9B
  - WNT10A
  - WNT10B
  - WNT11
  - WNT16
  - WNT5A
  - WNT5B
  - IKBKG
  - CTNNB1
  - CHUK
  - IKBKB
  - IKBKE
  - TBK1
  - ACACA
  - BMS1
  - ACACB
  - APP
  - AAAS
  - AAA1
  - HNF4A
  - NAT10
  - ERVW-4
  - MYC
  - CCND1
  - CDH2
  - ITK
  - SLC22A3
  - CDH1
  - FZR1
  - protein
  - m7G
  - AAA
  - Nucleus
  - Cancer
---
